A plain language summary of the SEQUOIA-HCM study: aficamten for symptomatic obstructive hypertrophic cardiomyopathy.
Maron MS, Olivotto I, van Sinttruije M. A plain language summary of the SEQUOIA-HCM study: aficamten for symptomatic obstructive hypertrophic cardiomyopathy. Future Cardiol. 2025 Jun; 21(7):415-432.